R Oklahoma Senate · District 10 On the 2026 ballot

Sen. Bill Coleman

Contact Email Phone Official site ↗

Compare

Session

Total votes

7,376

all sessions

Attendance

97%

160 missed

Near the chamber average

With party

98%

of cast votes

Higher than 93% of chamber peers

Bipartisan score

1%

crosses aisle rarely

Lower than 92% of chamber peers

Voting record

Yea

7,156

voted in favor

Nay

60

voted against

Absent

160

missed votes

Total cast

7,376

across all sessions

Crossed party

79

votes against own party

This page

7,376

matching current filters

Bill

Description

Vote

Result

Tally

Date

HB 2799

Sunset; Child Death Review Board; re-creating Board; modifying termination date.

Yea

Passed

12–0

Apr 5, 2023

HB 2809

Sunset; Board of Examiners in Optometry; extending sunset; emergency.

Yea

Passed

12–0

Apr 5, 2023

HB 2802

Sunset; certain advisory councils; re-creating councils; modifying termination dates.

Yea

Passed

11–1

Apr 5, 2023

HB 2815

Sunset; State Board of Behavioral Health Licensure; re-creating Board; modifying termination date.

Yea

Passed

10–2

Apr 5, 2023

HB 2811

Sunset; State Board of Licensed Social Workers; re-creating Board; modifying termination date.

Yea

Passed

10–2

Apr 5, 2023

HB 1738

Workers' compensation; death benefits; effective date.

Yea

Passed

9–0

Apr 4, 2023

HB 1712

Health insurance; prohibiting refusal of coverage under certain circumstances; out-of-network provider; reimbursement; codification; emergency.

Yea

Passed

9–0

Apr 4, 2023

HB 2376

State government; Personnel Act; longevity payments; leave benefits; increasing accumulation limits; computation of services; effective date; emergency.

Yea

Passed

9–0

Apr 4, 2023

HB 1736

Step therapy protocol; defining terms; requiring health benefit plans to implement a new process; exceptions to protocol; information; effective date.

Yea

Passed

8–0

Apr 4, 2023

HB 2748

Public health and safety; step therapy requirements for certain drugs for certain conditions; definitions; authorizing a health benefit plan to allow coverage for prescription drugs for advanced metastatic cancer and associated conditions without proving step therapy; effective date.

Yea

Passed

8–0

Apr 4, 2023